Arta Monjazeb
Overview
Explore the profile of Arta Monjazeb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
203
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Riess J, Lara M, Lopez de Rodas M, Luxardi G, Herbert S, Shimoda M, et al.
JTO Clin Res Rep
. 2024 Sep;
5(10):100706.
PMID: 39318388
Introduction: EGFR-mutated NSCLC is minimally responsive to programmed cell death protein 1 or programmed death-ligand 1 blockade. We evaluated the safety, tolerability, and immunomodulatory effects of the EGFR tyrosine kinase...
2.
Huynh J, Cho M, Monjazeb A, Al-Obeidi E, Singh A, Tam K, et al.
Invest New Drugs
. 2023 Dec;
42(1):35-43.
PMID: 38038862
Background: Indoleamine-2,3-dioxygenase (IDO) helps orchestrate immune suppression and checkpoint inhibitor resistance in hepatocellular carcinoma (HCC). BMS-986,205 is a novel oral drug that potently and selectively inhibits IDO. This Phase I/II...
3.
Demaria S, Guha C, Schoenfeld J, Morris Z, Monjazeb A, Sikora A, et al.
J Immunother Cancer
. 2021 Apr;
9(4).
PMID: 33827904
Recent evidence indicates that ionizing radiation can enhance immune responses to tumors. Advances in radiation delivery techniques allow hypofractionated delivery of conformal radiotherapy. Hypofractionation or other modifications of standard fractionation...
4.
Demisse R, Damle N, Kim E, Gong J, Fakih M, Eng C, et al.
J Natl Compr Canc Netw
. 2020 Jul;
18(7):798-804.
PMID: 32634770
Treatment options for locally advanced rectal cancer have continued to consist largely of chemotherapy, chemoradiation, and/or surgical resection. For patients who are unable to undergo these therapeutic modalities or who...
5.
Pai C, Hsiao H, Sun K, Chen M, Hagino T, Tellez J, et al.
Biol Blood Marrow Transplant
. 2014 Jul;
20(12):1899-904.
PMID: 25064746
Bortezomib, a proteasome inhibitor capable of direct antitumor effects, has been shown to prevent acute graft-versus-host disease (GVHD) when administered in a short course immediately after bone marrow transplantation (BMT)...
6.
Shah D, Borys D, Martinez S, Li C, Tamurian R, Bold R, et al.
Anticancer Res
. 2012 Sep;
32(9):3911-5.
PMID: 22993336
Unlabelled: We sought to determine if complete pathological necrosis (pathCR) predicts favorable oncological outcome in soft tissue sarcoma (STS) patients receiving pre-operative radiation monotherapy (RT). Patients And Methods: We evaluated...
7.
Kimple R, Russo S, Monjazeb A, Blackstock A
Expert Rev Anticancer Ther
. 2012 Apr;
12(4):469-80.
PMID: 22500684
Conflicting data and substantial controversy exist regarding optimal adjuvant treatment for those patients with resectable or potentially resectable adenocarcinoma of the pancreas. Despite improvements in short-term surgical outcomes, the use...
8.
Monjazeb A, Stanton C, Levine E
Am Surg
. 2004 Oct;
70(9):775-8.
PMID: 15481292
Liposarcomas are the most prevalent soft tissue sarcomas in adults. Low-grade liposarcomas are the most frequent and least aggressive and are noted as having a low risk of metastasis. We...
9.
Clay C, Monjazeb A, Thorburn J, Chilton F, High K
J Lipid Res
. 2002 Oct;
43(11):1818-28.
PMID: 12401880
Naturally occurring derivatives of arachidonic acid are potent agonists for the nuclear hormone receptor peroxisome proliferator-activated receptor gamma (PPARgamma) and block cancer cell proliferation through the induction of apoptosis. We...